Skip to content
Live funding
Sesame Summit 2027
Sesamers
N

Novo Holdings

● Actively deploying Copenhagen, Denmark

Investment thesis

Life science investor making venture, growth, credit and principal investments across the healthcare sector.

Sesamers tracks 4 portfolio companies across 5 rounds, 4 of them as lead investor. Its most recent tracked deal: OMass Therapeutics, Oct 2026.

Portfolio

Past investments

Company Round Role Date Round size
OMass Therapeutics Oxford, United Kingdom Series C Lead Oct 2026 €276.1M
AnaCardio Stockholm, Sweden Read the announcement → Series B Lead Sep 2026 €62.5M
Breye Therapeutics Hørsholm, Denmark Read the announcement → Series A Lead Sep 2026 €67.5M
Reduced Copenhagen, Denmark Series A Participant Feb 2026 €4M
Reduced Copenhagen, Denmark Seed Lead Apr 2024 €6M

Sesamers coverage

Get the weekly briefing Europe's rounds, founders & events - every Monday, in five minutes.